Implantable Biomaterials Market Technological Challenges, Market Update, Volume Analysis, Growth Prospects And Forecast 2023-2032

Spread the love

The Implantable Biomaterials Global Market Report 2023 by The Business Research Company, provides implantable biomaterials market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.

Learn More On The Implantable Biomaterials Market:

https://www.thebusinessresearchcompany.com/report/implantable-biomaterials-global-market-report

According to The Business Research Company’s Implantable Biomaterials Global Market Report 2023, the market size is expected to grow from$113.64 billion in 2022 to $127.97 billion in 2023 at a compound annual growth rate (CAGR) of 12.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global implantable biomaterials is expected to grow from $198.4 billion in 2027 at a CAGR of 11.6%.

The allocation of funds by government organizations in the development of new biomaterials [SR1] contributed to the implantable biomaterials market growth.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=3274&type=smp

The implantable biomaterials market is segmented:

1) By Material: Metallic, Ceramic, Polymers, Natural

2) By Application: Dental, Cardiovascular, Ophthalmology, Orthopedic, Other Applications

3) By End-user: Hospitals, Ambulatory Surgical Centers, Specialty Clinics

In April 2022, Integer Holdings Corporation, a US-based medical device company, acquired Connemara Biomedical Holdings Teoranta for an undisclosed amount. The acquisition would bring implantable biomaterial technology to Integer’s control and help its growth. Connemara Biomedical Holdings Teoranta is a Ireland-based manufacturer of biomaterials for cardiovascular implants.

The implantable biomaterials market report table of contents includes: